Skip to main content
Log in

Quantitative assessment of the association between GSTP1 gene Ile105Val polymorphism and susceptibility to hepatocellular carcinoma

  • Research Article
  • Published:
Tumor Biology

Abstract

Glutathione S-transferase P1 (GSTP1) gene Ile105Val polymorphism has been suggested to be involved in the development of cancer. However, the results from the studies regarding the association between GSTP1 Ile105Val polymorphism and hepatocellular carcinoma risk have been inconsistent. Thus, we performed a meta-analysis to investigate the association. Published literature from PubMed, Chinese Biomedical Literature, and Wanfang databases was searched for eligible publications. Pooled odds ratios (ORs) with 95 % confidence intervals (95 %CIs) were calculated using random- or fixed-effects model. Six studies with a total of 1,843 participants were finally included into this meta-analysis. The results suggested there was no association between GSTP1 Ile105Val polymorphism and hepatocellular carcinoma risk under all genetic models (for ValVal vs. IleIle, OR = 0.79, 95 %CI 0.48–1.29, P = 0.341; for IleVal vs. IleIle, OR = 1.05, 95 %CI 0.84–1.30, P = 0.678; for the dominant model, OR = 0.91, 95 %CI 0.68–1.20, P = 0.498; and for the recessive model, OR = 0.76, 95 %CI 0.47–1.24, P = 0.269). Subgroup analyses by ethnicity showed there was also no association between GSTP1 Ile105Val polymorphism and hepatocellular carcinoma risk in Asians under all genetic models (All P values were more than 0.05), but GSTP1 Ile105Val polymorphism was associated with decreased risk of hepatocellular carcinoma in European under the recessive model (ValVal vs. IleVal/IleIle) (OR = 0.44, 95 %CI 0.20–0.98, P = 0.044). In conclusion, the meta-analysis suggests that there is little evidence for the association between GSTP1 Ile105Val polymorphism and hepatocellular carcinoma risk. However, more well-designed studies are needed to further assess this association.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245–55.

    Article  PubMed  Google Scholar 

  2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  3. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–27.

    Article  PubMed  CAS  Google Scholar 

  4. McCarver DG, Hines RN. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther. 2002;300:361–6.

    Article  PubMed  CAS  Google Scholar 

  5. Vasieva O. The many faces of glutathione transferase pi. Curr Mol Med. 2011;11:129–39.

    Article  PubMed  CAS  Google Scholar 

  6. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res. 2001;482:21–6.

    Article  PubMed  CAS  Google Scholar 

  7. Townsend D, Tew K. Cancer drugs, genetic variation and the glutathione-S-transferase gene family. Am J Pharmacogenomics. 2003;3:157–72.

    Article  PubMed  CAS  Google Scholar 

  8. Ginsberg G, Smolenski S, Hattis D, Guyton KZ, Johns DO, Sonawane B. Genetic polymorphism in glutathione transferases (GST): population distribution of GSTM1, T1, and P1 conjugating activity. J Toxicol Environ Health B Crit Rev. 2009;12:389–439.

    Article  PubMed  CAS  Google Scholar 

  9. Tang YT, Li XP, Liu TQ, Yang JR, Luo JQ, Liang ZX. A study of genetic polymorphisms of glutathione S-transferase in patients with hepatocellular carcinoma. Zhong Guo Shi Yan Zhen Duan Xue. 2012;16:660–2.

    Google Scholar 

  10. Chen YL, Tseng HS, Kuo WH, Yang SF, Chen DR, Tsai HT. Glutathione S-transferase p1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma. BMC Med Genet. 2010;11:46.

    Article  PubMed  Google Scholar 

  11. White DL, Li D, Nurgalieva Z, El-Serag HB. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a huge systematic review and meta-analysis. Am J Epidemiol. 2008;167:377–89.

    Article  PubMed  Google Scholar 

  12. Ladero JM, Martinez C, Fernandez JM, Martin F, Garcia-Martin E, Ropero P, et al. Glutathione S-transferases pi 1, alpha 1 and m3 genetic polymorphisms and the risk of hepatocellular carcinoma in humans. Pharmacogenomics. 2007;8:895–9.

    Article  PubMed  CAS  Google Scholar 

  13. Munaka M, Kohshi K, Kawamoto T, Takasawa S, Nagata N, Itoh H, et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2003;129:355–60.

    Article  PubMed  CAS  Google Scholar 

  14. Liu CZ, Bian JC, Jiang F, Shen FM. Genetic polymorphisms of glutathione S-transferase m1, t1, and p1 on susceptibility to hepatocellular carcinoma. Zhongguo Geng Gong Wei Sheng. 2002;18:935–6.

    CAS  Google Scholar 

  15. Chen SY, Wang LY, Lunn RM, Tsai WY, Lee PH, Lee CS, et al. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int J Cancer. 2002;99:14–21.

    Article  PubMed  CAS  Google Scholar 

  16. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.

    Article  Google Scholar 

  17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  PubMed  CAS  Google Scholar 

  18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    PubMed  CAS  Google Scholar 

  19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  PubMed  CAS  Google Scholar 

  20. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51–88.

    Article  PubMed  CAS  Google Scholar 

  21. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154–66.

    Article  PubMed  CAS  Google Scholar 

  22. Strange RC, Fryer AA. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ. 1999;148:231–49.

    PubMed  CAS  Google Scholar 

  23. Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, et al. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol. 2010;53:508–18.

    Article  PubMed  Google Scholar 

  24. Lu S, Wang Z, Cui D, Liu H, Hao X. Glutathione S-transferase p1 ile105val polymorphism and breast cancer risk: a meta-analysis involving 34,658 subjects. Breast Cancer Res Treat. 2011;125:253–9.

    Article  PubMed  CAS  Google Scholar 

  25. Economopoulos KP, Sergentanis TN, Vlahos NF. Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk: a meta-analysis. Int J Gynecol Cancer. 2010;20:732–7.

    Article  PubMed  Google Scholar 

  26. Economopoulos KP, Sergentanis TN. GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis. Eur J Cancer. 2010;46:1617–31.

    Article  PubMed  CAS  Google Scholar 

  27. Zhou Y, Li N, Zhuang W, Yin YQ, Liu GJ, Wu TX, et al. Glutathione S-transferase P1 gene polymorphism associated with gastric cancer among Caucasians. Eur J Cancer. 2009;45:1438–42.

    Article  PubMed  CAS  Google Scholar 

  28. Mo Z, Gao Y, Cao Y, Gao F, Jian L. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a huge review. Prostate. 2009;69:662–88.

    Article  PubMed  CAS  Google Scholar 

  29. Chen X, Liang L, Hu X, Chen Y. Glutathione S-transferase P1 gene Ile105Val polymorphism might be associated with lung cancer risk in the Chinese Han population. Tumour Biol. 2012;33:1973–81.

    Article  PubMed  CAS  Google Scholar 

  30. Yao L, Ji G, Gu A, Zhao P, Liu N. An updated pooled analysis of glutathione S-transferase genotype polymorphisms and risk of adult gliomas. Asian Pac J Cancer Prev. 2012;13:157–63.

    Article  PubMed  Google Scholar 

  31. Zhao ZQ, Guan QK, Yang FY, Zhao P, Zhou B, Chen ZJ. System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk. Tumour Biol. 2012;33:523–35.

    Article  PubMed  CAS  Google Scholar 

  32. Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008;61:634–45.

    Article  PubMed  Google Scholar 

  33. Yu L, Sun L, Jiang YF, Lu BL, Sun DR, Zhu LY. Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: evidence from epidemiological studies. Mol Biol Rep. 2012;39:6641–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qiang Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, Y., Wang, Q., Deng, X. et al. Quantitative assessment of the association between GSTP1 gene Ile105Val polymorphism and susceptibility to hepatocellular carcinoma. Tumor Biol. 34, 2121–2126 (2013). https://doi.org/10.1007/s13277-013-0695-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-0695-1

Keywords

Navigation